C85.93 Non-Hodgkin lymphoma, unspecified, intra-abdominal lymph nodes

Name of the Condition

• Common Name: Non-Hodgkin Lymphoma
• Medical Term: Non-Hodgkin lymphoma, unspecified, intra-abdominal lymph nodes
• ICD Code: C85.93

Summary

Non-Hodgkin lymphoma (NHL) is a group of blood cancers that affect the lymphatic system, part of the immune system. This code is used when the specific subtype of NHL is not clearly defined and the lymphoma is located in the intra-abdominal lymph nodes. The lymphatic system helps fight infections, and NHL arises from abnormal lymphocyte growth.

Causes

The exact cause of non-Hodgkin lymphoma is often unknown but involves genetic mutations in lymphocytes. Factors such as viral infections, immune system disorders, or exposure to certain chemicals may contribute to its development. These mutations disrupt normal cell regulation, leading to uncontrolled growth.

Risk Factors

• Advanced age (more common in older adults)
• Weakened immune system (e.g., HIV/AIDS, immunosuppressive therapy)
• Certain infections (e.g., hepatitis C, H. pylori)
• Exposure to chemicals (e.g., pesticides, herbicides)
• Family history of lymphoma
• Autoimmune conditions (e.g., rheumatoid arthritis)

Symptoms

• Swollen lymph nodes in the abdomen
• Abdominal pain or swelling
• Fever, night sweats, or unexplained weight loss
• Fatigue or weakness
• Nausea or vomiting
• Changes in bowel habits

Diagnosis

Diagnosis typically involves a combination of physical examination, imaging studies (e.g., CT or MRI scans), blood tests, and a biopsy of the affected lymph nodes. Additional tests, such as bone marrow biopsy or PET scans, may be used to assess the extent of the disease.

Treatment Options

• Chemotherapy: Uses drugs to destroy cancer cells.
• Radiation therapy: Targets specific areas to reduce tumor size.
• Immunotherapy: Boosts the immune system to fight cancer.
• Stem cell transplant: Replaces damaged bone marrow with healthy cells.
• Targeted therapy: Uses drugs to target specific cancer cell characteristics.

Prognosis and Follow-Up

Prognosis depends on factors like the subtype, stage, and overall health. Regular follow-up appointments, including imaging and blood tests, are essential to monitor for recurrence or progression. Treatment may be adjusted based on response and side effects.

Complications

• Organ damage from tumor growth or treatment
• Increased risk of infections due to weakened immunity
• Anemia or bleeding disorders
• Lymphedema (swelling from lymph node removal)
• Secondary cancers from treatment

Lifestyle & Prevention

• Maintain a healthy diet and regular exercise to support immune function.
• Avoid exposure to known carcinogens (e.g., pesticides, tobacco).
• Manage stress and get adequate rest.
• Stay up-to-date with vaccinations to reduce infection risk.
• Limit alcohol consumption.

When to Seek Professional Help

Seek medical attention if you experience persistent abdominal swelling, unexplained weight loss, fever, or fatigue. Prompt evaluation is important for early diagnosis and treatment.

Tips for Medical Coders

Use this code when the diagnosis is non-Hodgkin lymphoma with an unspecified subtype and the site is confirmed as intra-abdominal lymph nodes. Ensure documentation supports the anatomical location to justify code assignment. Verify that no more specific subtype or site code is applicable before using C85.93.